(5S)-5-[(3R)-3-(4-chlorophenyl)butyl]-3-[(1S)-1-(4-chlorophenyl)ethyl]-1,3-oxazolidin-2-one;methane
C22H27Cl2NO2 — CID 158004525
Data last refreshed: (MolForge compound catalog, from PubChem)
About (5S)-5-[(3R)-3-(4-chlorophenyl)butyl]-3-[(1S)-1-(4-chlorophenyl)ethyl]-1,3-oxazolidin-2-one;methane
(5S)-5-[(3R)-3-(4-chlorophenyl)butyl]-3-[(1S)-1-(4-chlorophenyl)ethyl]-1,3-oxazolidin-2-one;methane (PubChem CID 158004525) has the molecular formula C22H27Cl2NO2 and a molecular weight of 408.37 g/mol. Its IUPAC name is (5S)-5-[(3R)-3-(4-chlorophenyl)butyl]-3-[(1S)-1-(4-chlorophenyl)ethyl]-1,3-oxazolidin-2-one;methane.
Molecular Properties
| Compound Name | (5S)-5-[(3R)-3-(4-chlorophenyl)butyl]-3-[(1S)-1-(4-chlorophenyl)ethyl]-1,3-oxazolidin-2-one;methane |
|---|---|
| PubChem CID | 158004525 |
| Molecular Formula | C22H27Cl2NO2 |
| Molecular Weight | 408.37 g/mol |
| Exact Mass | 407.14 |
| IUPAC Name | (5S)-5-[(3R)-3-(4-chlorophenyl)butyl]-3-[(1S)-1-(4-chlorophenyl)ethyl]-1,3-oxazolidin-2-one;methane |
| SMILES | C.C[C@H](CC[C@H]1CN([C@@H](C)c2ccc(Cl)cc2)C(=O)O1)c1ccc(Cl)cc1 |
| InChI | InChI=1S/C21H23Cl2NO2.CH4/c1-14(16-4-8-18(22)9-5-16)3-12-20-13-24(21(25)26-20)15(2)17-6-10-19(23)11-7-17;/h4-11,14-15,20H,3,12-13H2,1-2H3;1H4/t14-,15+,20+;/m1./s1 |
| InChIKey | FECXWWGHGYYANR-MGDWOKRKSA-N |
| XLogP | 7.10 |
| TPSA | 29.54 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 408.37 |
| LogP ≤ 5 | 7.10 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158004525 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.